Structure–Activity Relationship Studies Leading to the Discovery of Highly Water-Soluble and Biocompatible Acyclic Cucurbit[<i>n</i>]uril FY-3451 as a Universal Antagonist That Rapidly Reverses Neuromuscular Blocking Agents <i>In Vivo</i>
Ke Feng, Yue-Yang Liu, Yang Zong, Zhuo Lei, Yan Wu, Jingyu Yang, Furong Lin, Qiao‐Yan Qi, Q. Li, Sheng‐Yi Zhuang, Jiangshan Zhang, Jia Tian, Wei Zhou, Da Ma, Dan‐Wei Zhang, Zhan‐Ting Li, Shang‐Bo Yu
Abstract
The development of a reversal agent that can rapidly reverse clinically used nondepolarizing neuromuscular blocking agents (NMBAs) has long been a challenge. Here, we report the synthesis of a series of highly water-soluble acyclic cucurbit[ n ]urils (acCBs). Systematic structure–activity relationship studies reveal that introducing two propylidene units on the peripheral benzene rings not only remarkably improves the activity of the corresponding derivative acCB6 (FY 3451) in reversing the neuromuscular block of rocuronium, cisatracurium, vecuronium, and pancuronium, the four clinically used NMBAs, through stable inclusion, but also allows for high water-solubility as well as a maximum tolerated dose (2000 mg/kg on rats). In vivo experiments with rats show that, at the identical dose of 25 mg/kg, for rocuronium, vecuronium, and pancuronium, acCB6 can achieve a recovery time shorter than that of sugammadex for rocuronium and, at the dose of 100 mg/kg, realize comparably rapid reversal for cisatracurium.